{"created":"2024-12-18T00:14:40.430529+00:00","id":2000236,"links":{},"metadata":{"_buckets":{"deposit":"51dcc3ca-e699-4245-877e-19cd70da7a90"},"_deposit":{"created_by":12,"id":"2000236","owners":[12],"pid":{"revision_id":0,"type":"depid","value":"2000236"},"status":"published"},"_oai":{"id":"oai:fujita-hu.repo.nii.ac.jp:02000236","sets":["63:132:1731541551121"]},"author_link":["3613"],"control_number":"2000236","item_10006_alternative_title_1":{"attribute_name":"タイトル(別言語)","attribute_value_mlt":[{"subitem_alternative_title":"エルロチニブで治療中の進行非小細胞肺癌の外来患者に対して薬剤師外来の介入が与える影響","subitem_alternative_title_language":"ja"}]},"item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2024-09-26"}]},"item_10006_degree_grantor_9":{"attribute_name":"item_10006_degree_grantor_9","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"藤田医科大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"33916","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_10006_degree_name_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士(医学)","subitem_degreename_language":"ja"}]},"item_10006_dissertation_number_12":{"attribute_name":"dissertation_number","attribute_value_mlt":[{"subitem_dissertationnumber":"乙第592号"}]},"item_10006_relation_16":{"attribute_name":"item_10006_relation_16","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_language":"en","subitem_relation_name_text":"Biol Pharm Bull. 2021 Sep 1;44(9):1280-1285."}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1248/bpb.b21-00167","subitem_relation_type_select":"DOI"}}]},"item_10006_rights_31":{"attribute_name":"item_10006_rights_31","attribute_value_mlt":[{"subitem_rights":"©2021 The Pharmaceutical Society of Japan"}]},"item_10006_version_type_18":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Toyosato, Seira","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"3613","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"3613","nameIdentifierScheme":"WEKO著者ID"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2024-12-25"}],"displaytype":"simple","filename":"乙592_要旨.pdf","filesize":[{"value":"497.0 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"要旨","objectType":"abstract","url":"https://fujita-hu.repo.nii.ac.jp/record/2000236/files/乙592_要旨.pdf"},"version_id":"ca3d850d-8e83-49fb-a517-7421520f69c9"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2024-12-25"}],"displaytype":"simple","filename":"乙592_本文.pdf","filesize":[{"value":"525.1 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"本文","objectType":"fulltext","url":"https://fujita-hu.repo.nii.ac.jp/record/2000236/files/乙592_本文.pdf"},"version_id":"836d8c50-4b3c-4c91-8d10-ba193d642676"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"item_resource_type","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"The Influence of Intervening on the Pharmaceutical Consultation Targeting Outpatients with Advanced Non-small Cell Lung Cancer Receiving Erlotinib Treatment","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"The Influence of Intervening on the Pharmaceutical Consultation Targeting Outpatients with Advanced Non-small Cell Lung Cancer Receiving Erlotinib Treatment","subitem_title_language":"en"}]},"item_type_id":"10006","owner":"12","path":["1731541551121"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-12-25"},"publish_date":"2024-12-25","publish_status":"0","recid":"2000236","relation_version_is_last":true,"title":["The Influence of Intervening on the Pharmaceutical Consultation Targeting Outpatients with Advanced Non-small Cell Lung Cancer Receiving Erlotinib Treatment"],"weko_creator_id":"12","weko_shared_id":-1},"updated":"2025-06-06T04:52:34.790541+00:00"}